Decreased sensitivity to 1,25-dihydroxyvitamin D3 in T cells from the rheumatoid joint
Journal of Autoimmunity Nov 08, 2017
Jeffery LE, et al. - This study was implemented to assess the efficacy of 1,25-dihydroxyvitaminD3 (1,25(OH)2D3) in terms of its anti-inflammatory effects, at the site of active rheumatoid arthritis (RA). As suggested by findings, anti-inflammatory impacts of 1,25(OH)2D3 in active RA are impaired due to reduced effects on phenotype-committed, inflammatory memory T cells that are enriched in synovial fluid (SF). As per observations, restoration of 1,25(OH)2D3 responses in memory T cells may provide a new strategy for treatment of inflammatory diseases such as RA.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries